Article in Acta crystallographica. Section F, Structural biology communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Chi L NguyenBiochemistry Program, Vassar College, 124 Raymond Avenue, Poughkeepsie, NY 12604, USA.ORCID 0000-0003-0914-3801
Abigail R TramellBiochemistry Program, Vassar College, 124 Raymond Avenue, Poughkeepsie, NY 12604, USA.
Jordan O NormanBiochemistry Program, Vassar College, 124 Raymond Avenue, Poughkeepsie, NY 12604, USA.
Jan AbendrothSeattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA.ORCID 0000-0002-8229-3243
Kayleigh F BarrettSeattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA.
Justin K CraigSeattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA.
Thomas E EdwardsSeattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA.ORCID 0000-0002-0474-8003
Donald D LorimerSeattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA.ORCID 0000-0002-9638-8083
Wesley C Van VoorhisCenter for Emerging and Re-emerging Infectious Diseases (CERID), Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98195, USA.ORCID 0000-0001-6141-2015
Krystle J McLaughlinBiochemistry Program, Vassar College, 124 Raymond Avenue, Poughkeepsie, NY 12604, USA.ORCID 0000-0003-4105-1042
Funding
Centers for Research on Structural Biology of Infectious Diseases: Universal Influenza Vaccine Research75N93022C00036 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI STAKER, BART · 2022 to 2025
$21.7M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
Cellular deoxyuridine 5'-triphosphate nucleotidohydrolases (dUTPases) catalyze the hydrolysis of deoxyuridine triphosphate (dUTP) to deoxyuridine monophosphate (dUMP) and pyrophosphate (PP
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Structural characterization of dUTPase from Legionella pneumophila. · full record | OpenQuestion